Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

13.210
-0.260-1.93%
Volume:2.40M
Turnover:31.85M
Market Cap:7.85B
PE:-74.52
High:13.540
Open:13.420
Low:13.150
Close:13.470
52wk High:28.600
52wk Low:10.870
Shares:594.00M
HK Float Shares:594.00M
Volume Ratio:1.32
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.177
ROE:-9.57%
ROA:-8.91%
PB:6.11
PE(LYR):-74.52
PS:49.24

Loading ...

Biotech Stocks Plunge Amid Global Bond Selloff and Rising Interest Rate Concerns

Stock News
·
May 18

Hong Kong Market Closes Down 1.62%, Retreats Below 26,000 as U.S. Bond Jitters Weigh; Robotics Sector Bucks the Trend

Stock News
·
May 15

Hong Kong Stocks Slide as Trump-Xi Talks Leave Investors Unimpressed; CARsgen Therapeutics Falls

MT Newswires Live
·
May 15

CARsgen Therapeutics to Raise HK$462 Million via Top-Up Placement

MT Newswires Live
·
May 15

BRIEF-CARsgen Therapeutics Announces Placing Of Up To 23.7 Million Shares At HK$19.84 Per Share

Reuters
·
May 15

CARSGEN-B Shareholder Deposits Shares with UBS Securities Hong Kong, Valued at HKD 1.927 Billion

Stock News
·
May 15

CARSGEN-B Announces Discounted Share Placement to Raise Approximately HK$462 Million

Stock News
·
May 15

CARsgen prices 23,700,000-share placement at HK$ 19.84 per share

Reuters
·
May 15

CARsgen Therapeutics Holdings Ltd - Placing Price of up to 23.7 Mln Shares at HK$19.84 per Share

THOMSON REUTERS
·
May 15

Stock Track | CARsgen-B Soars 6.01% Intraday on Positive CAR-T Therapy Milestones

Stock Track
·
May 13

Stock Track | CARsgen-B Soars 5.91% Intraday on Pipeline Catalyst with Universal CAR-T Therapy Data Acceptance at EHA

Stock Track
·
May 07

CARSGEN-B Shares Rise Over 3% at Opening as EHA Congress Accepts CT0596 and CT1190B Study Abstracts for Poster Presentation

Deep News
·
May 06

CARSGEN-B Shares Climb Over 3% as EHA Congress Accepts Abstracts for CT0596 and CT1190B Studies

Stock News
·
May 06

High Growth Tech Stocks In Asia To Watch April 2026

Simply Wall St.
·
Apr 30

CARsgen to Present CT0596 and CT1190B Allogeneic CAR-T Data at the 2026 EHA Congress

Bulletin Express
·
Apr 27

CARSGEN-B Announces Acceptance of CT0596 and CT1190B Study Abstracts for Poster Presentation at 2026 EHA Congress

Stock News
·
Apr 27

Stock Track | CARSGEN-B Plummets 5.04% Intraday on Profit-Taking After Lancet Publication Rally

Stock Track
·
Apr 22

Stock Track | CARSGEN-B Soars 10.92% Intraday as CAR-T Therapy Research Published in The Lancet

Stock Track
·
Apr 20

CARSGEN-B 2025年业绩:收入约1.2566亿元,净亏损显著收窄

Bulletin Express
·
Apr 10

CARsgen reiterates shift to electronic dissemination of corporate communications

Bulletin Express
·
Apr 10